Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Abbvie Inc

Recent news which mentions Abbvie Inc

< Previous 1 2 Next >
Jim Cramer suggests why it's hard to own traditional 'safety' stocks here
Tags Colgate/Palmolive Co Business News Stock markets
From CNBC.com News
Novo Nordisk cuts 2025 guidance on weaker-than-expected Wegovy sales, posts first-quarter profit beat
Tags LILLY DRN Business News Biotechnology
From CNBC.com News
Trump signs order to boost domestic drug manufacturing as pharma tariff threat looms
Tags Biotech and Pharmaceuticals Abbvie Inc Politics
From CNBC.com News
Inside the deal: Roche and Zealand Pharma's $5.3 billion obesity drug gambit
Tags Mergers Amgen Inc Pharmaceuticals
From CNBC.com News
Healthy Returns: Here are the drugmakers with new U.S. investments as Trump’s pharma tariffs loom
Tags Merck & Co Inc LILLY DRN Healthy Returns
From CNBC.com News
Cramer's week ahead: Earnings from Tesla, Alphabet, Capital One and Boeing
Tags Stock Picks Raytheon Technologies Corp General Electric Co
From CNBC.com News
Pharmaceutical stocks fall as Trump doubles down on tariffs threat
Tags Health care industry Bristol/Myers Squibb Co Pharmaceuticals
From CNBC.com News
Trump's tariffs are a new challenge for Big Pharma. Here are the best positioned stocks
Tags Breaking News: Investing Biogen Inc LILLY DRN
From CNBC.com News
Ad spending on women's sports more than doubled last year
Tags Television Nike Inc Abbvie Inc
From CNBC.com News
Healthy Returns: AbbVie is the newest potential weight loss drug market player
Tags AstraZeneca PLC Salesforce Inc Alphabet Inc
From CNBC.com News
Cramer's Lighting Round: AbbVie is a buy
Tags Market Outlook Business News Hims & Hers Health Inc
From CNBC.com News
Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
Tags Novo Nordisk A/S Abbvie Inc Biotech and Pharmaceuticals
From CNBC.com News
Wednesday's big stock stories: What’s likely to move the market in the next trading session
Tags New York Times Co Investment strategy Tesla Inc
From CNBC.com News
Cramer's Lightning Round: Sweetgreen is 'terrific'
Tags Investment Strategy Stock Picks Investment strategy
From CNBC.com News
Friday's big stock stories: What’s likely to move the market in the next trading session
Tags stocks Boston Scientific Corp Walmart Inc
From CNBC.com News
Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations
Tags Merck & Co Inc Business News Biotechnology
From CNBC.com News
Healthy Returns: What drugmakers are saying about final negotiated prices with Medicare
Tags Bristol/Myers Squibb Co Health care industry Politics
From CNBC.com News
Healthy Returns: Sales of Humira are plunging, but AbbVie has two promising successors
Tags Health care industry Health & Science UnitedHealth Group Inc
From CNBC.com News
AbbVie taps longtime executive Robert Michael as new CEO, succeeding Richard Gonzalez
Tags Health & Science Business Health care industry
From CNBC.com News
After 8 months stuck in orbit, Varda's drug spacecraft gets FAA approval to return
Tags Abbvie Inc Space Transportation
From CNBC.com News
Cramer's Lightning Round: AbbVie is 'a very good company'
Tags Business stocks MercadoLibre Inc
From CNBC.com News
Big pharma is at a crossroads, as J&J, Merck and others prepare to lose heaps of revenue from blockbuster drugs
Tags Merck & Co Inc Business News Biotechnology
From CNBC.com News
J&J to acquire cancer drug developer Ambrx Biopharma for $2 billion
Tags Business Health & Science Biotech and Pharmaceuticals
From CNBC.com News
Cramer names biopharma companies to watch as industry mergers start to pile up
Tags Business News Pfizer Inc Bristol/Myers Squibb Co
From CNBC.com News
Pfizer shares fall as 2024 revenue and profit forecast disappoints
Tags Bristol/Myers Squibb Co Health care industry Pharmaceuticals
From CNBC.com News
5 things to know before the stock market opens Thursday
Tags JPMORGAN DRN Abbvie Inc ImmunoGen Inc
From CNBC.com News
AbbVie to acquire neuroscience drugmaker Cerevel Therapeutics for $8.7 billion
Tags Health care industry Pharmaceuticals Cerevel Therapeutics Holdings Inc
From CNBC.com News
Biotech stocks jump on AbbVie deal to buy cancer drugmaker ImmunoGen for $10 billion
Tags Health care industry Pharmaceuticals Companies
From CNBC.com News
Here are 16 stocks Jim Cramer is watching, including Microsoft, Chevron, Southwest
Tags Valley National Bancorp CNBC Investing Club: Newsletter Investment strategy
From CNBC.com News
Cramer's Lightning Round: Energy Transfer is a buy
Tags Portillos Inc Salesforce Inc stocks
From CNBC.com News
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.